Heparin-induced thrombocytopenia.
Warkentin
T E
TE
Kelton
J G
JG
D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D001792:Blood Platelets / Q000276:immunology; D002417:Cattle; D015331:Cohort Studies; D006025:Glycosaminoglycans / Q000737:chemistry; D006474:Hemorrhagic Disorders / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects* / Q000737:chemistry; D006496:Heparinoids / Q000009:adverse effects / Q000737:chemistry; D006497:Heparan Sulfate / Q000737:chemistry; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D011446:Prospective Studies; D013329:Structure-Activity Relationship; D013552:Swine; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D013927:Thrombosis / Q000139:chemically induced
D001323:Autoantibodies; D006025:Glycosaminoglycans; D006493:Heparin; D006496:Heparinoids; D006497:Heparan Sulfate; D007074:Immunoglobulin G